NDC 63323-280-01 - Furosemide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-280
- Requested NDC
- 63323-280-01
- Package NDCs from labels
- 63323-280-01, 63323-280-02, 63323-280-03, 63323-280-04, 63323-280-05, 63323-280-10, 63323-280-41, 63323-280-16, 63323-280-43, 63323-280-26, 63323-280-45, 63323-280-36
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-10-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-06-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Furosemide - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-12-09 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-22 | HUMAN PRESCRIPTION DRUG LABEL |
| FUROSEMIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2021-06-28 | HUMAN PRESCRIPTION DRUG LABEL |
| Model AA-8565CV-ACT Model AA-8565CV - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-280-01 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 6 | |
| 63323-280-02 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-03 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 6 | |
| 63323-280-04 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-05 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 6 | |
| 63323-280-10 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 6 | |
| 63323-280-16 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-26 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-36 | Furosemide | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 5 | |
| 63323-280-41 | Furosemide | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 5 | |
| 63323-280-43 | Furosemide | 4 mL in 1 VIAL | INJECTION, SOLUTION | 4 | 5 | |
| 63323-280-45 | Furosemide | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 6 package rows | 20241222_c794c95a-654e-48fe-9596-201fc122ff75.zip |
| 63323-280 | FUROSEMIDE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | Current NDC, Legacy NDC, 6 package rows | 20241222_3747bbcd-783d-4baa-bb5b-b6827bf390e3.zip |
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FUROSEMIDE | ACTIVE INGREDIENT | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| FUROSEMIDE | ACTIVE MOIETY | 7LXU5N7ZO5 | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | FUROSEMIDE INJECTION, SOLUTION [APP PHARMACEUTICALS, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMAZON BASICS ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 3c2914a4-913e-7e50-e063-6294a90aff3a | 2026-03-18 | Warnings | 362O9ITL9D |
| Furosemide | FUROSEMIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | ANDA203428 23155-473 1719290 1719291 1719286 c14acada-333e-43bb-b1cf-81d569e3e918 1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec 7LXU5N7ZO5 |
| M-Dryl | DIPHENHYDRAMINE HYDROCHLORIDE | Bryant Ranch Prepack | f9a0fb35-46d6-434f-8f9a-425a4bf50e84 | 2026-03-18 | Warnings | TC2D6JAD40 |
| Altachlore Sodium Chloride Hypertonicity Ophthalmic 5 Percent | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | e13fd053-9420-490c-a43e-e14b0930cb4e | 2026-03-18 | Warnings | 451W47IQ8X |
| Universaltox | ALFALFA, AVENA SATIVA, FUCUS VESICULOSUS, HORDEUM VULGARE, NASTURTIUM AQUATICUM, RAPHANUS SATIVUS, TRITICUM AESTIVUM, IODIUM, UBIDECARENONUM, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, MANGANESE GLUCONATE, ORYZA SATIVA, THYROIDINUM (SUIS), CALCAREA CARBONICA, NATRUM MURIATICUM, PULSATILLA (PRATENSIS), RHUS TOX, CORTISONE ACETICUM | BioActive Nutritional, Inc. | ad454e8a-4f78-4aac-90d9-a3f26a6fbe42 | 2026-03-17 | Warnings | 451W47IQ8X |
| Dextrose | DEXTROSE MONOHYDRATE | Becton Dickinson and Company | 8e7046f8-841e-465a-af69-af9fb3d6799d | 2026-03-17 | Warnings, Adverse reactions | LX22YL083G |
| BUTALBITAL AND ACETAMINOPHEN | BUTALBITAL AND ACETAMINOPHEN | Amici Pharma, Inc. | 3280501f-928a-4112-803d-fb9771c86547 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Otoflam HP | BELLADONNA, CONIUM MACULATUM, DULCAMARA, HEPAR SULPHURIS CALCAREUM, KALI BICHROMICUM, MERCURIUS SOLUBILIS, PULSATILLA (VULGARIS), SILICEA, CHAMOMILLA | BioActive Nutritional, Inc. | 12f1ef62-93f3-45b8-885d-1b82f85a8355 | 2026-03-17 | Warnings | ETJ7Z6XBU4 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | Grocery Outlet | 7398a372-7679-423b-a3ca-8da905a979dd | 2026-03-17 | Warnings | R16CO5Y76E 362O9ITL9D |
| OSKIN New York Coffee BB Cream SPF 30 | TITANIUM DIOXIDE, OCTOCRYLENE, ZINC OXIDE | O'Skin Studio NY | 29dae75a-4368-432a-9cf8-f0f021f09e29 | 2026-03-17 | Warnings | 15FIX9V2JP |
| TINTED SUNSCREEN FOUNDATION | TINTED SUNSCREEN FOUNDATION | Guanghzou AiXin Biotech Co Ltd | 396393c4-b50c-3877-e063-6294a90a0e9b | 2026-03-17 | Warnings | 059QF0KO0R |
| Premier Tinted Mineral Sunscreen | BROAD SPECTRUM SPF30 | Premier Plastic Surgery | 4d39b64c-2e27-afed-e063-6394a90a3812 | 2026-03-17 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d39ed7a-ca80-893c-e063-6294a90a03e7 | 2026-03-17 | Warnings | 15FIX9V2JP |
| Powder | TITANIUM DIOXIDE | Oxygen Development LLC | 4d3a0a92-b0de-a1ea-e063-6294a90a8508 | 2026-03-17 | Warnings | 15FIX9V2JP |
| MediChoice OB Cleansing | BENZALKONIUM CHLORIDE | O&M HALYARD, INC. | ed38fb97-b67d-430b-8f6b-4fc78c16aead | 2026-03-17 | Warnings | M003 1038558 F5UM2KM3W7 |
| MedPRIDE | ISOPROPYL ALCOHOL | Shield Line LLC | f2177bd3-259d-4231-88b2-4a98e48e4df6 | 2026-03-17 | Warnings | M003 ND2M416302 |
| MedPride 91% Rubbing Alcohol | ISOPROPYL ALCOHOL | Shield Line LLC | e6ffe41e-efdc-0e0a-e053-2995a90a9e6a | 2026-03-17 | Warnings | M003 ND2M416302 |
| MedPRIDE with Wintergreen Oil | ISOPROPYL ALCOHOL | Shield Line LLC | 57ac1a5c-758a-4422-8795-40391584434a | 2026-03-17 | Warnings | M003 ND2M416302 |
| NOVITA ISOPROPYL ALCOHOL 50% | ISOPROPYL ALCOHOL | Shield Line LLC | 3ad79e91-377d-6587-e054-00144ff8d46c | 2026-03-17 | Warnings | M003 ND2M416302 |
| NOVITA 50% ISOPROPYL RUBBING ALCOHOL W/ WINTERGREEN | ISOPROPYL ALCOHOL | Shield Line LLC | 3bd9fc61-b135-51f5-e054-00144ff8d46c | 2026-03-17 | Warnings | M003 ND2M416302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.